ACMSD and kidney disorder: On the basis of the discovery of TES-1025 and related analogs, we have established valuable tools for a better understanding of the therapeutic applications of ACMSD inhibitors for disorders such as mitochondrial dysfunctions and metabolic and renal diseases, associated with the dysregulation or reduced NAD+ levels.